New drug aims to keep ulcerative colitis in check for years
NCT ID NCT07185009
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 27 times
Summary
This study tests a new medicine called duvakitug for people with moderate to severe ulcerative colitis. Participants who already responded to duvakitug in an earlier study will continue treatment for up to 5 years to see if it safely maintains remission. The goal is to control the disease long-term, not cure it.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BVL Clinical Research - Site Number: 8400005
RECRUITINGLiberty, Missouri, 64068, United States
-
Bioresearch Partner-Kendale Lakes - Site Number: 8400053
RECRUITINGMiami, Florida, 33155, United States
-
Clinical Research of Osceola - Site Number: 8400013
RECRUITINGKissimmee, Florida, 34741, United States
-
Cross Creek Medical Clinic - Site Number: 8400057
RECRUITINGFayetteville, North Carolina, 28304, United States
-
Delta Research Partners - Site Number: 8400087
RECRUITINGMonroe, Louisiana, 71291, United States
-
GI Alliance - Baton Rouge - Site Number: 8400129
RECRUITINGBaton Rouge, Louisiana, 70809, United States
-
Investigational Site Number : 1240003
RECRUITINGToronto, Ontario, M6A 3B4, Canada
-
Investigational Site Number : 3920019
RECRUITINGKobe, 650-0015, Japan
-
Investigational Site Number : 3920029
RECRUITINGSapporo, 004-0041, Japan
-
Investigational Site Number : 3920030
RECRUITINGKamakura, 247-0056, Japan
-
Investigational Site Number : 6880001
RECRUITINGBelgrade, 11,000, Serbia
-
Investigational Site Number : 6880002
RECRUITINGBelgrade, 11000, Serbia
-
NMC Research LLC - Site Number: 8400033
RECRUITINGTampa, Florida, 33607, United States
-
New York Gastroenterology Associates - Site Number: 8400009
RECRUITINGNew York, New York, 10075, United States
-
Ohio Gastroenterology Group Inc. - Site Number: 8400006
RECRUITINGColumbus, Ohio, 43202, United States
-
Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039
RECRUITINGColorado Springs, Colorado, 80907, United States
-
Royal Palm Clinical Research - Site Number: 8400065
RECRUITINGFort Myers, Florida, 33901, United States
-
Southern California GI & Liver Centers - Site Number: 8400062
RECRUITINGCoronado, California, 92118, United States
-
Tokai University Hachioji Hospital - Site Number : 3920031
RECRUITINGHachiōji, 192-0032, Japan
-
Tyler Research Institute, LLC - Site Number: 8400095
RECRUITINGTyler, Texas, 75701, United States
Conditions
Explore the condition pages connected to this study.